This inventor holds 27 USPTO granted patents and 14 published patent applications, plus 6 CIPO patents and 10 EPO patents, primarily in Corneal Cell Therapy. Top assignees: Kyoto Prefectural Public University Corporation, Senju Pharmaceutical Co., Ltd., The Doshisha. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2012 - 2023)
- Kyoto, JP (2011 - 2024)
Company Filing History:
16 out of 60 
12 out of 229 
8 out of 86 
Years Active: 2011-2026
Areas of Expertise:
Certainly! Here is the article about inventor Shigeru Kinoshita:
Title: Shigeru Kinoshita: Innovating for Ophthalmological Advancements
Introduction: Shigeru Kinoshita, a distinguished inventor hailing from Kyoto, Japan, has made significant contributions to the field of ophthalmology with his innovative patents.
Latest Patents:
1. **Treatment of Retina and Nerve using Laminin:** Kinoshita's groundbreaking technique focuses on treating retinal epithelium and nerves. By utilizing laminin and its fragments, his agent offers a novel approach to address retinal diseases and ophthalmological nerve conditions.
2. **Agent for Promoting Corneal Endothelial Cell Adhesion:** Another notable invention by Kinoshita is an agent designed to enhance the adhesion of corneal endothelial cells. Through the inclusion of a Rho kinase inhibitor, this innovation paves the way for improved corneal health treatments.
Career Highlights:
Shigeru Kinoshita has showcased his expertise at renowned institutions such as the Kyoto Prefectural Public University Corporation and Senju Pharmaceutical Co., Ltd., where he has consistently pushed the boundaries of ophthalmological research and development.
Collaborations:
Throughout his career, Kinoshita has collaborated closely with esteemed professionals in the field, including Noriko Koizumi and Naoki Okumura. Together, they have synergized their efforts to drive forward cutting-edge advancements in ophthalmic care.
Conclusion:
In conclusion, Shigeru Kinoshita's relentless dedication to pioneering innovations in ophthalmology has not only expanded the realm of possibilities for treatment solutions but also exemplified the profound impact that inventors can have on improving healthcare outcomes globally.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile